Inseego (INSG) Director Receives 9,427 RSU Grant; Vesting Sept 2026

Rhea-AI Filing Summary

Harland Christopher, a director of Inseego Corp. (INSG), reported acquiring 9,427 restricted stock units (RSUs) on 09/12/2025 that settle 1-for-1 into common shares. After the reported grant, he beneficially owns 49,764 shares in total. The RSUs carry a $0 purchase price and are scheduled to vest on September 10, 2026. The Form 4 was signed by an attorney-in-fact on 09/16/2025. The filing documents a standard insider equity award with future vesting rather than an open-market purchase or sale.

Positive

• Insider ownership increased via a grant of 9,427 RSUs, raising beneficial holdings to 49,764 shares
• Clear vesting schedule disclosed: RSUs scheduled to vest on September 10, 2026, providing alignment with long‑term shareholder interests
• Transaction type is compensation (RSUs), not a sale, indicating retention/incentive rather than cashing out

Negative

• None.

Insights

Financial Analyst

TL;DR: Director received time‑based RSUs increasing insider stake; no cash paid and vesting is deferred to 2026.

The reported transaction is a non‑derivative grant of 9,427 RSUs that convert 1:1 into common stock and carry a reported price of $0, indicating a compensation award rather than an open‑market acquisition. The grant increases the director's beneficial ownership to 49,764 shares, which modestly aligns management incentives with shareholders but will only affect dilution and ownership upon vesting on September 10, 2026. There are no sales, option exercises, or derivative transactions disclosed in this filing.

Corporate Governance Expert

TL;DR: Routine equity compensation disclosure; timing and vesting terms are standard and disclosed.

The Form 4 properly discloses a time‑based restricted stock unit award for a director. The $0 price and one‑for‑one settlement are consistent with RSU grants issued as compensation. The vesting date is specified, meeting disclosure expectations for Section 16 insiders. The filing does not indicate any related party transactions, accelerated vesting, or abnormal transfer that would raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Harland Christopher

(Last) (First) (Middle)

9710 SCRANTON ROAD, SUITE 200

(Street)

SAN DIEGO CA 92121

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INSEEGO CORP. [ INSG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/12/2025		A		9,427(1)	A	$0	49,764	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units ("RSUs") that settle for shares of common stock on a 1-for-1 basis. The RSUs are scheduled to vest on September 10, 2026.

	/s/ Kurt E. Scheuerman, Attorney-in-Fact	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did INSG director Harland Christopher report on the Form 4?

He reported receiving 9,427 RSUs on 09/12/2025 that settle 1:1 into common stock, increasing his beneficial ownership to 49,764 shares.

Do the reported RSUs have a purchase price?

The Form 4 reports a price of $0, indicating these units were issued as compensation rather than bought on the open market.

When do the RSUs vest for the INSG director?

The RSUs are scheduled to vest on September 10, 2026, per the filing's explanatory note.

Was this Form 4 signed by the reporting person?

The filing was signed by an attorney‑in‑fact (Kurt E. Scheuerman) on 09/16/2025 as indicated on the form.

Does the Form 4 show any sales or derivative transactions by the director?

No; the filing only discloses a non‑derivative grant of RSUs and no dispositions or derivative positions.